Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients

Next Previous
Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients

Status: Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs LP 003 Longbio Pharma (Primary)
  • Indications Food hypersensitivity
  • Focus Adverse reactions
  • Sponsors LongBio Pharma

Most Recent Events

  • 27 Aug 2026 Status changed from planning to not yet recruiting.
  • 02 Mar 2025 According to Longbio Pharma media release, the company plans to initiate this clinical trial in the near future.
  • 25 Nov 2024 According to a LongBio Pharma media release, company announced that the National Medical Products Administration (NMPA, China) has approved the Investigational New Drug (IND) application for LP-003 for the treatment of food allergy.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top